Michael D. Blaszyk serves as Executive at Abraxis BioScience, Inc., where they oversee executive responsibilities. Since joining the company, Michael D. Blaszyk has executed 11 insider transactions totaling $198.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 5, 2023 involved purchasing 485 shares valued at $1.3K.
Michael D. Blaszyk currently holds 71,915 shares of Abraxis BioScience, Inc. (ABBI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael D. Blaszyk has been a net buyer of ABBI stock. They have purchased $198.0K and sold $0 worth of shares.
Michael D. Blaszyk's most recent insider trade was on Jun 5, 2023, when they purchased 485 shares at $2.75 per share.
Get notified when new Form 4 filings are submitted
| $2.72 |
| Discretionary |
| Jun 5, 2023 | IBRX | $133.0K | Purchase | 48,000 | $2.77 | Discretionary |
| Jun 6, 2019 | NK | $0 | Award | 92,592 | $N/A | Discretionary |
| Sep 6, 2018 | NH | $0 | Award | 45,002 | $N/A | Discretionary |
| Sep 6, 2018 | NH | $0 | Award | 52,910 | $N/A | Discretionary |
| Jun 7, 2018 | NK | $0 | Award | 27,322 | $N/A | Discretionary |
| Nov 6, 2017 | NH | $0 | Award | 50,868 | $N/A | Discretionary |
| Jun 9, 2017 | NK | $0 | Award | 23,753 | $N/A | Discretionary |
| May 13, 2016 | NK | $0 | Award | 50,000 | $N/A | Discretionary |
| Aug 1, 2006 | ABBI | $150.5K | Award | 7,500 | $20.07 | Discretionary |